Literature DB >> 33905786

Association between vaccination and autoimmune bullous diseases: A systematic review.

Michael Kasperkiewicz1, David T Woodley2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33905786     DOI： 10.1016/j.jaad.2021.04.061

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  9 in total

1.  Case Report: Circulating Anti-SARS-CoV-2 Antibodies Do Not Cross-React With Pemphigus or Pemphigoid Autoantigens.

Authors:  Michael Kasperkiewicz; Marta Bednarek; Stefan Tukaj
Journal:  Front Med (Lausanne)       Date:  2021-12-20

2.  Bullous pemphigoid after SARS-CoV-2 vaccination: spike-protein-directed immunofluorescence confocal microscopy and T-cell-receptor studies.

Authors:  T Gambichler; N Hamdani; H Budde; M Sieme; M Skrygan; L Scholl; H Dickel; B Behle; N Ganjuur; C Scheel; N Abu Rached; L Ocker; R Stranzenbach; M Doerler; L Pfeiffer; J C Becker
Journal:  Br J Dermatol       Date:  2022-01-20       Impact factor: 11.113

3.  Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study.

Authors:  Carlo Alberto Maronese; Marzia Caproni; Chiara Moltrasio; Giovanni Genovese; Pamela Vezzoli; Paolo Sena; Giulia Previtali; Emanuele Cozzani; Giulia Gasparini; Aurora Parodi; Laura Atzori; Emiliano Antiga; Roberto Maglie; Francesco Moro; Elena Biancamaria Mariotti; Alberto Corrà; Sabatino Pallotta; Biagio Didona; Angelo Valerio Marzano; Giovanni Di Zenzo
Journal:  Front Med (Lausanne)       Date:  2022-02-28

4.  Association between vaccination and immunobullous disorders: a brief, updated systematic review with focus on COVID-19.

Authors:  M Kasperkiewicz; D T Woodley
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-03-07       Impact factor: 9.228

5.  Bullous pemphigoid following COVID-19 vaccine: An autoimmune disorder.

Authors:  Aneesh Rai; Govinda Khatri; Mohammad Mehedi Hasan
Journal:  Ann Med Surg (Lond)       Date:  2022-07-31

Review 6.  Pemphigus during the COVID-19 Epidemic: Infection Risk, Vaccine Responses and Management Strategies.

Authors:  Xueyi Huang; Xiaoqian Liang; Jiao Zhang; Hang Su; Yongfeng Chen
Journal:  J Clin Med       Date:  2022-07-08       Impact factor: 4.964

7.  Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association?

Authors:  Nika Kianfar; Shayan Dasdar; Ali Salehi Farid; Kamran Balighi; Hamidreza Mahmoudi; Maryam Daneshpazhooh
Journal:  Front Med (Lausanne)       Date:  2022-07-19

8.  New onset of pemphigus foliaceus following BBIBP COVID-19 vaccine.

Authors:  Mohammadreza Pourani; Farahnaz Bidari-Zerehpoosh; Azin Ayatollahi; Reza M Robati
Journal:  Dermatol Ther       Date:  2022-09-12       Impact factor: 3.858

Review 9.  Patient Quality of Life Improvement in Bullous Disease: A Review of Primary Literature and Considerations for the Clinician.

Authors:  Jessica J Padniewski; Rob L Shaver; Brittney Schultz; David R Pearson
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-01-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.